The Chinese biotech is also entitled to an equity stake in Oblenio Bio, according to the release. Leads developed LBL-051 ...

US company IDEAYA Biosciences has exercised the option for an exclusive worldwide license for Biocytogen Pharmaceuticals’ ...

Exosome research products market in China is rapidly expanding, driven by significant government funding, cutting-edge ...

Shares of AstraZeneca dropped more than 7% yesterday after the Chinese publication Yicai Global reported that dozens of ...

Merck KGaA is shaping up to take on Daiichi Sankyo and Ono Pharma in the market for tenosynovial giant cell tumour (TGCT) ...

BEIJING, Nov 10 (Reuters) - China and Indonesia signed deals worth $10 billion at the Indonesia-China Business Forum in ...

Kennedy Jr. have on vaccines in the U.S.? We have a look at that question today, discuss another U.S. biotech launch using Chinese science, and more. President-elect Trump’s decision to entrust ...

Nourish Ingredients announces partnership with CABIO Biotech to manufacture and distribute its animal-free fat ingredient ...

The five-year investment will go toward the construction of a new R&D facility in Beijing to develop innovative therapies and integrate the world’s second most populated country into the company’s ...

The companies’ first cross-continental collaboration is expected to be mutually beneficial as they seek to expand the reach ...

2. Pfizer’s China 2030 plan includes $1B investment, collaboration with local biotech (National Business Daily, Chinese) Pfizer plans to invest $1 billion in China from 2025 to 2030, the company ...